CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
This is a prospective, open-label, multi-cohort, non-randomized, multicenter phase 2 study evaluating LN-145 in patients with metastatic non...
Phase 2
Columbus, Ohio, United States and 43 other locations
type of side effects may occur with the drug treatment. It will also measure the levels of drug in the body and preliminarily assess its anti-cancer...
Phase 1, Phase 2
Columbus, Ohio, United States and 123 other locations
This is a phase 3 study to evaluate zimberelimab (AB122) combined with domvanalimab (AB154) compared to pembrolizumab in front-line, PD-L1-high, loca...
Phase 3
Columbus, Ohio, United States and 167 other locations
This study is being done to determine the efficacy and safety of cofetuzumab pelidotin in the PTK7-expressing, recurrent non-small ...
Phase 1
Columbus, Ohio, United States and 25 other locations
This is an open-label, multicenter, non-randomized, Phase 2 study to determine the safety, tolerability and efficacy of encorafenib given in-...
Phase 2
Columbus, Ohio, United States and 157 other locations
pembrolizumab as maintenance therapy in patients with stage IV non-squamous non-small cell lung cancer...
Phase 1, Phase 2
Columbus, Ohio, United States and 2 other locations
An Open Label, Multi-Center, Dose Escalation/Expansion, Phase 1/1b Study of IMU 201 (PD1-Vaxx), a B-Cell Immunotherapy as monotherapy or in -...
Phase 1
Columbus, Ohio, United States and 5 other locations
Stage IB, IIA, IIB, IIIA, or selected IIIB resectable and untreated non-small cell lung cancer (NSCLC) t...
Phase 2
Columbus, Ohio, United States and 33 other locations
This phase Ib trial tests the safety, side effects, and best dose of the combination of vismodegib and atezolizumab in treating patients with non...
Phase 1
Columbus, Ohio, United States
in previously untreated patients with locally advanced or metastatic non-squamous Non-Small Cell Lung Ca...
Phase 3
Columbus, Ohio, United States and 206 other locations
Clinical trials
Research sites
Resources
Legal